It’s always better to prevent a disease than to treat it. Vaccine prevent disease in the people who receive them. If enough people are vaccinated against a disease, then the disease cannot spread into their community. This is known as “Community Immunity.”
How do Vaccines Protect from Diseases?
When our immune system recognizes germs that enter the body as “foreign” invaders, or antigens it works not only to clear your body of that invader, but also creates a large number of memory cells that are specifically tuned to react to it. This protection is called immunity. Vaccines contain little bits of a disease – broken down and harless, and when injected, stimulate the production of antibodies. Through vaccination, we develop immunity without suffering from the actual diseases that vaccines prevent.
The Burden of Influenza
- $24.6 billion in economic costs per year in the U.S. related to influenza and pneumonia
New vaccinations for emerging diseases and for infections that have been prevalent in the past offer hope for a healthier future for all.
What can I do?
RCR is currently seeking healthy volunteers for several investigational vaccine research studies. If you are over the age of 18, you could participate in one of the following investigational vaccine studies:
Rochester Clinical Research is currently seeking volunteers to participate in a pneumococcal and flu vaccine study. This study is for people who are 50 years or older and want to protect themselves against these two very contagious viruses before the Winter season. This study is approximately 7 months long and consists of 3 office visits and 4 telephone call check-ins. The purpose of the study is to test the safety and efficacy of the vaccine targeting the two viruses and different stains of the flu. If you qualify to participate, compensation will be provided for your time and travel. View Trial Details
Rochester Clinical Research is currently seeking volunteers who are 18 years and older for an Influenza vaccine study. The purpose of this study will be to evaluate the safety and immunogenicity of an mRNA vaccine to prevent influenza. Compensation for time and travel is available for around $630 to those who qualify. View Trial Details
Rochester Clinical Research is currently seeking volunteers over the age of 18 to participate in an omicron variant booster vaccine study. This paid research study is testing the efficacy and tolerability of an omicron variant-specific vaccine. The purpose of this vaccine is to provide extra protection against the highly contagious strain. The study is about 6 months long and requires 5 visits to the office. View Trial Details
Rochester Clinical Research is seeking volunteers who are 50 years and older to participate in an mRNA flu vaccine study. The purpose of this study is to evaluate the effectiveness of using mRNA technology in a flu vaccine at protecting against different variants. Since the normal flu vaccines are only about 60% effective, doctors believe that this will result in better protection results. This is a phase 3 study and is about 12 months long with only one visit to our office. View Trial Details
Rochester Clinical Research is now seeking volunteers between the ages of 18 and 49 years old for a Pneumococcal vaccine study. This paid research study hopes to find a new pneumococcal vaccine that will potentially protect against strains not covered by the currently available vaccines. The study is approximately 6 months long and you can get up to $555 in study-related compensation. View Trial Details
Rochester Clinical Research is participating in a study evaluating the immune response of a single dose of the Chikungunya vaccine in healthy adolescents between the ages of 12 and 17 years old. The study will last approximately 6 months with 7 visits to our office. Compensation is available for up to $650 for time and travel, for those who qualify. View Trial Details
Dengue fever is a virus that is carried by mosquitoes, usually in subtropical and tropical climates. Symptoms can range from either being mild or severe. The virus only lasts about a week, but if left untreated it could turn into severe symptoms. We are conducting a phase 2 study of a vaccine for people ages 18-50 years old to test the safety and efficiency of different doses given. It’s a one-year-long trial with 8 visits to the office. View Trial Details
Chikungunya is a virus that can be spread through mosquito bites similar to other mosquito-spread illnesses like Zika, malaria, dengue, and West Nile Virus. RCR is conducting a study to test the effectiveness of a phase 3 vaccine to prevent Chikungunya in people who are 65 or older. The study will be 7 months long and consists of 5 office visits and 2 phone call appointments. View Trial Details
Rochester Clinical Research is now seeking volunteers between the ages of 65 and 85 years old for an influenza vaccine study. The purpose of this research study is to evaluate the safety and effectiveness of an investigational influenza vaccine versus a currently approved influenza vaccine. View Trial Details
Rochester Clinical Research is now enrolling volunteers between the ages of 18 and 75 years old for an investigational COVID vaccine booster plus flu vaccine study. View Trial Details
Rochester Clinical Research wants to help advance treatments for people who suffer from episodic migraines. We are conducting a study that is three months long and requires you to come in once a month to receive an injection. RCR is seeking healthy individuals between the ages of 18-65 who get 4-14 migraines a month to participate. This is a phase 4 study and Rochester Clinical research wants to help get this treatment FDA-approved so that people no longer have to let migraines slow down their day. View Trial Details
Rochester Clinical Research is seeking volunteers over the age of 18 for a COVID-19 vaccine study to potentially protect against specific variants of COVID-19. View Trial Details
Rochester Clinical Research is currently seeking born-female volunteers between the ages of 16 and 40 years old to participate in a CMV vaccine study. The purpose of this study is to find a safe and effective vaccine against Cytomegalovirus. View Trial Details
Rochester Clinical Research is currently seeking adults over the age of 64 years old for different RSV vaccine studies. Join an RSV vaccine study that is testing the efficacy of a vaccine that may prevent lower respiratory tract disease, which is associated with the RSV virus. The study will last about 24 to 30 months and consists up to 6 office visit and a monthly telephone appointment. Compensation may be up to $1,640 for time and travel to participate in the study. View Trial Details